Chonluten 20 mg

Chonluten is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a synthetic tripeptide with the sequence Glu-Asp-Gly (EDG), Chonluten was developed to investigate how minimal peptide sequences interact with bronchial epithelial tissue and pulmonary mucosal research models. Its compact structure positions Chonluten as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Chonluten is studied for its proposed ability to engage with chromatin structure and modulate transcriptional activity within bronchial epithelial cells and respiratory mucosal cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with epithelial renewal, mucosal-barrier maintenance, and cytokine-related signaling in airway-derived cell systems. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Chonluten centers on lung-tissue gene expression studies, bronchial epithelial renewal research models, and mucosal regulation investigations. Comparative work on tissue-specific bioregulators positions Chonluten alongside other respiratory-targeted oligopeptides used to explore peptidergic regulation of pulmonary biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the EDG sequence influences epithelial gene-expression profiles in bronchial research models, supporting continued laboratory investigation of Chonluten in pulmonary and mucosal biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Bronchogen 20 mg, Thymogen, and Cartalax 20 mg.

Specifications

• Purity: 99%
• Quantity: 20 mg
• CAS Number: 75007-24-8
• Molecular Formula: C₁₁H₁₇N₃O₈
• Molecular Weight: ~319.27 g/mol